ABSTRACT
In 1998, Governor Paul E. Patton established the Kentucky Breast Cancer Task Force (KBCTF) to assess and make recommendations on the availability, accessibility, utilization, quality, and outcomes of breast cancer services across the spectrum of disease. Over a two-year period, the KBCTF reviewed the state of breast cancer control in Kentucky and made recommendations for reducing breast cancer morbidity and mortality. To achieve the provision of optimal breast cancer care, the KBCTF recommended universal adoption of professionally accepted guidelines for breast cancer treatment, pain management, and distress management. To better coordinate public education on breast cancer, the KBCTF recommended the development of a standardized packet of public education materials for dissemination through regional networks of "cancer control partners." KBCTF members also requested the Kentucky Cancer Program to investigate the feasibility of establishing a centralized mammography registry to gather more complete data on screening mammography programs.
Subject(s)
Breast Neoplasms/prevention & control , State Health Plans/organization & administration , Breast Neoplasms/epidemiology , Continuity of Patient Care/standards , Female , Health Education , Health Planning , Humans , Insurance, Health/statistics & numerical data , Kentucky , Mammography/statistics & numerical data , Quality of Health Care , United StatesSubject(s)
Breast Neoplasms/prevention & control , Community Health Planning/organization & administration , Leadership , Medically Underserved Area , Outcome and Process Assessment, Health Care , Rural Health , Uterine Cervical Neoplasms/prevention & control , Appalachian Region/epidemiology , Breast Neoplasms/mortality , Cooperative Behavior , Female , Health Care Coalitions , Humans , National Institutes of Health (U.S.) , Pilot Projects , Program Evaluation/methods , Social Change , United States , Universities , Uterine Cervical Neoplasms/mortalityABSTRACT
This paper provides strategies to improve communication between clinicians and patients, particularly patients who are among the 44 million adult Americans with low literacy skills. Included are insights into the nature of the literacy problem and how it affects patient comprehension of information across the continuum of cancer care. Practical strategies address how to help patients understand medical advice, reduce literacy levels of cancer information, and help patients remember the advice given. A summary of the strategies is included in the Appendix for convenient reference.
Subject(s)
Communication , Educational Status , Neoplasms/therapy , Patient Education as Topic , Physician-Patient Relations , Adult , Humans , Pamphlets , Patient Compliance , ReadingABSTRACT
PURPOSE: The authors describe a framework for developing an effective, community-focused cancer control program. OVERVIEW: Progress in the application of cancer control interventions has proven to be quite variable across different populations and communities. The Kentucky Cancer Program, developed under joint sponsorship of cancer centers at two state universities, has been using a model that appears to provide a high degree of sensitivity to community-specific problems and solutions. The Kentucky four-step model includes 1) using data from a population-based cancer registry and other sources to identify problems; 2) ensuring community involvement with providers in selecting the target population and developing the intervention strategy; 3) implementing the intervention plan; and 4) using cancer registry and other data to evaluate the impact of this intervention. CLINICAL IMPLICATIONS: This framework may be useful to providers as they try to balance the goals of their clinical practice and the goals of community cancer control. Developing an effective, community-focused cancer control program requires that providers gain a solid knowledge about their community. The depth and richness of that knowledge base is enhanced by the active participation of community members as they collaborate with the providers on planning and implementing cancer control activities.
Subject(s)
Breast Neoplasms/prevention & control , Community Networks , Health Personnel , Mass Screening , Uterine Cervical Neoplasms/prevention & control , Breast Neoplasms/epidemiology , Female , Humans , Kentucky/epidemiology , Program Evaluation , Uterine Cervical Neoplasms/epidemiologyABSTRACT
Risk factors for superficial and invasive bladder cancer were examined in a case-control study of 470 cases identified in 1967-68 in the Brockton and Boston Standard Metropolitan Areas (MA, United States) and of 500 population-based controls. Histologic specimens were reviewed and classified as superficial or invasive, following a standardized protocol. The tobacco-associated risk for superficial bladder cancer was odds ratio (OR) = 2.6 (95 percent confidence interval [CI] = 1.7-4.1) and the risk for invasive bladder cancer was OR = 1.7 (CI = 1.1-2.5). For subjects less than 60 years of age, the risks were greater for invasive tumors (OR = 4.3, CI = 1.2-15) than for superficial tumors (OR = 2.0, CI = 0.9-4.2), but this pattern for tobacco use was not found in older subjects. A strong trend of increased risk with increased amount of cigarettes smoked was shown only for invasive bladder tumors. No clear pattern of excess risk for invasive bladder tumors was seen for age at first use and years since last use of tobacco. The risk associated with occupational exposure to aromatic amine bladder carcinogens was OR = 1.7 (CI = 0.8-3.3) for superficial and OR = 1.5 (CI = 0.8-3.0) for invasive bladder cancer. For subjects less than 60 years of age, the risks were greater for invasive (OR = 12.0, CI = 2.1-65) than for superficial tumors (OR = 4.3, CI = 0.8-24), but this pattern for occupational exposure was not found in older subjects.(ABSTRACT TRUNCATED AT 250 WORDS)
Subject(s)
Amines/adverse effects , Smoking/adverse effects , Urinary Bladder Neoplasms/pathology , Age Factors , Aged , Case-Control Studies , Humans , Middle Aged , Neoplasm Invasiveness , Occupational Exposure , Risk , Risk Factors , Urinary Bladder Neoplasms/epidemiologyABSTRACT
An estimated one in five Americans is functionally illiterate; they lack the literacy skills to access information or to perform many other basic tasks vital to their health and well-being. The National Cancer Institute and its Cancer Information Service have been working since 1990 to develop cancer-education strategies and materials to reach people with limited literacy skills. This paper reviews the link between cancer and illiteracy, the magnitude of the problem, and the association between cancer, certain health-related behaviors, and educational attainment. It also examines innovative National Cancer Institute and Cancer Information Service programs and materials designed to reach this high-risk population.
Subject(s)
Educational Status , Information Services , Medical Oncology/education , HumansABSTRACT
A total of 178 patients with grade 1 noninvasive (stage Ta) bladder tumors followed from 1 to 10 years (median 58 months) was prospectively evaluated by cystoscopy, transurethral resection, mucosal biopsies, cytology, size and number of tumors at diagnosis, recurrences, progression in grade and stage, number of negative or positive cystoscopies and death from all causes. Histopathological and cytological studies were confirmed by a Central Pathology Laboratory using the criteria for grade 1 as described previously. Of the patients 122 (68.5%) had a single tumor. Three-quarters of the patients had tumors of less than 2 cm., 95% had mild or no urothelial dysplasia and 1 had positive cytology results. There were 419 recurrent tumors in 109 patients (61%). Patients with multiple tumors were at a significantly greater risk for recurrences (p < 0.001). Size of tumor significantly affected the rate of recurrence in the first 2 years after initial diagnosis in single tumor patients only. Of the multiple tumor patients 90% experienced a recurrence compared to 46% of the single tumor patients. Of the 1,112 cystoscopies performed in 122 single tumor patients 18% were positive, compared to 33% of the 686 cystoscopies performed in 56 multiple tumor patients. A total of 29 patients had a change in grade, 5 having grade 3 and 24 having grade 2 tumors. Progression to stage T1 occurred in 5 patients and to stage T2 or greater in 3. Of the 36 patients who died, 1 died of obstruction due to bladder cancer. Experimental evidence supports the opinion that the cells of stage Ta, grade 1 tumors are different in several ways from normal urothelium. There are little data to support the use of the term papilloma to describe stage Ta, grade 1 tumors without reservation. The data demonstrate that the tumor diathesis being expressed ceases with time and for unknown reasons. Multiple tumor patients with stage Ta, grade 1 disease might be included in chemotherapy trials only with stratification and a control arm of transurethral resection/fulguration alone.
Subject(s)
Carcinoma, Transitional Cell/therapy , Urinary Bladder Neoplasms/therapy , Adult , Aged , Aged, 80 and over , Carcinoma, Transitional Cell/mortality , Carcinoma, Transitional Cell/pathology , Female , Humans , Male , Middle Aged , Neoplasm Recurrence, Local , Survival Rate , Urinary Bladder Neoplasms/mortality , Urinary Bladder Neoplasms/pathologyABSTRACT
BACKGROUND: Cervical cancer mortality rates in the Appalachian population of southeastern Kentucky have been shown to be unusually high. To better understand the high cervical cancer death rate in this area, we developed a population-based cervical disease registry. PURPOSE: This study describes the incidence of cervical dysplasia, carcinoma in situ, and invasive cervical cancer in 1986 and 1987 among White women in a 36-county area of Appalachian Kentucky based on histologic diagnoses. METHODS: We compared average annual age-adjusted incidence rates for carcinoma in situ and invasive cervical cancer in the study area with those for women in the Surveillance, Epidemiology, and End Results (SEER) Program. RESULTS: The incidence rate of invasive cervical cancer for women in the study area (14.9 per 100,000) was nearly twice that for White women in the SEER population (7.8 per 100,000), but it was similar to that for Black women in the SEER population (15.3 per 100,000). The incidence of carcinoma in situ for women in the study population (38.2 per 100,000) was 21% higher than that for White women (31.5 per 100,000) or for Black women (31.2 per 100,000) in the SEER population. The average annual age-adjusted incidence rate for all grades of dysplasia among women in the study population was 194.6 per 100,000. No comparable population-based incidence rates for dysplasia could be identified. CONCLUSIONS: Cervical cancer incidence rates are higher in Appalachian Kentucky than in the SEER population. Poverty appears to be a factor associated with these rates. IMPLICATIONS: Low-density populations such as those in rural Appalachia deserve greater attention in cancer control research. The population-based cervical dysplasia rates reported here may be useful for comparisons in future investigations.
Subject(s)
Uterine Cervical Dysplasia/epidemiology , Uterine Cervical Neoplasms/epidemiology , Appalachian Region/epidemiology , Carcinoma in Situ/epidemiology , Female , Humans , Incidence , Kentucky/epidemiology , Neoplasm Invasiveness , Population Surveillance , Poverty , Rural HealthSubject(s)
Neoplasms/prevention & control , Academic Medical Centers , Cancer Care Facilities , Humans , KentuckySubject(s)
Health Policy , Reimbursement Mechanisms , Breast Neoplasms/therapy , Female , Humans , Mammography/economics , Public Policy , United StatesABSTRACT
A prospective study of comparable Japanese and British breast cancer patients treated by radical mastectomy confirmed previously reported findings that sinus histiocytosis and germinal center hyperplasia are more frequently seen in axillary lymph nodes from Japanese than in those from British patients. In Japanese, but not British, cases of either of these two morphologic findings had favorable prognostic significance for recurrence. Sinus histiocytosis also had favorable prognostic significance in Japanese cases for five year survival. In a separate review of axillary nodes from Japanese autopsy cases sinus histiocytosis was absent, suggesting that this finding in Japanese breast cancer cases was related to presence of the disease.
Subject(s)
Breast Neoplasms/pathology , Histiocytosis, Sinus/pathology , Lymph Nodes/pathology , England , Female , Humans , Hyperplasia , Japan , Lymphatic Metastasis , Prognosis , RecurrenceABSTRACT
Cervical cancer screening and demonstration projects to identify barriers to optimal screening are discussed. Interview surveys showed that older women and women in low-income groups tended to have lower rates of Papanicolaou smear screening. Data produced by demonstration projects established by the Centers for Disease Control in collaboration with state and local authorities and private institutions will be used to design and implement strategies for increasing screening levels to further reduce cervical cancer mortality.
Subject(s)
Health Services Accessibility/trends , Mass Screening/trends , Uterine Cervical Neoplasms/prevention & control , Women's Health Services/trends , Age Factors , Attitude to Health , Centers for Disease Control and Prevention, U.S. , Female , Humans , Papanicolaou Test , Pilot Projects , Socioeconomic Factors , United States , Uterine Cervical Neoplasms/mortality , Vaginal Smears/statistics & numerical dataSubject(s)
Brachytherapy , Carcinoma/therapy , Radiotherapy, High-Energy , Urinary Bladder Neoplasms/therapy , Urinary Bladder/surgery , Carcinoma/mortality , Combined Modality Therapy , Female , Humans , Male , Middle Aged , Preoperative Care , Prognosis , Risk Factors , Urinary Bladder Neoplasms/mortalityABSTRACT
Selection of optimal primary therapy for bladder cancer patients requires a multidisciplinary approach based on an evaluation of the location, extent and, if possible, the virulence of the tumor(s), and the host response. Currently, cystoscopic observation and morphologic assessment of cellular and tissue specimens are the main sources of information. The urologist and pathologist are chiefly responsible for collecting this information, but other laboratory approaches also are being developed. The urologist must prepare a "seen at cystoscopy" diagram of the bladder mucosal surface and indicate in both the diagram and the cystoscopy report the number, location and appearance of tumors and other abnormalities. The cytopathologist must be as precise as possible in defining abnormalities in cellular preparations, and the histopathologist must not only indicate the microscopic diagnosis but the presence or absence of muscle in each biopsy specimen.